33 Harbour Square
Suite 202
Toronto, Ontario M5J 2G2
Canada
Telephone
416-364-2551
Fax
416-364-9363
CERTIFICATIONS & ACCREDITATIONS
COMPANY EXECUTIVES
Gluskin, Anna E. (Board); Perri, Rose C. (Board); Von Hofe, Eric; Ali, Munaf; Bernstein, Gerald (Prior Board); Fletcher, Mark A.; Humphreys, Robert E.; Rubinfeld, Joseph; Xu, Minzhen; Abajian, William D.
BOARD MEMBERS
Gluskin, Anna E. (Board); Perri, Rose C. (Board); Barratt, John P. (Board); Masterson, Nola Elizabeth (Board); McGee, Brian T. (Board)
COMPETITORS
Micromet, Inc. (NasdaqGM:MITI); Johnson & Johnson (NYSE:JNJ); Emisphere Technologies, Inc. (OTCBB:EMIS); Eli Lilly & Co. (NYSE:LLY); Sanofi Pasteur, Inc.; MannKind Corp. (NasdaqGM:MNKD); Aradigm Corp. (OTCBB:ARDM); Pfizer Inc. (NYSE:PFE); Nektar Therapeutics (NasdaqGS:NKTR); Advaxis Inc. (OTCBB:ADXS); Barr Pharmaceuticals, Inc.; Novo Nordisk A/S (CPSE:NOVO B); Purdue Pharmaceuticals L.P.; CEL-SCI Corp. (AMEX:CVM); Oramed Pharmaceuticals Inc. (OTCBB:ORMP); Pharmexa-Epimmune Inc.; Alkermes, Inc. (NasdaqGS:ALKS); Cell Genesys, Inc. (NasdaqGM:CEGE); Dendreon Corp. (NasdaqGM:DNDN); MGI Pharma Biologics; Kos Pharmaceuticals, Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Generex Biotechnology Corp.
Generex Biotechnology Corporation, a development stage company, engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases. It develops a proprietary platform technology for the oral administration of large molecule drugs, including proteins, peptides, monoclonal antibodies, hormones, and vaccines. The company’s products include Generex Oral-lyn, an insulin spray formulation used for the treatment of Type-1 and Type-2 diabetes; Glucose RapidSpray, which provides an alternative for people who require additional glucose in their diet, as well as delivers glucose formulation directly into the mouth; BaBOOM! Energy Spray, an instant energy spray designed to increase energy levels for sports, work, study, travel, and overall fatigue; and GlucoBreak, a fat-free glucose spray. Generex Biotechnology Corporation’s under development products include medicinal chewing gum for the treatment of Type-2 diabetes mellitus and obesity; and morphine and fentanyl products for breakthrough and postoperative pain. The company markets its products through distributors and retail chains in Ecuador, Canada, and the United States. It has collaboration with Fertin Pharma A/S. The company was founded in 1983 and is based in Toronto, Canada.
